{
    "clinical_study": {
        "@rank": "132828", 
        "brief_summary": {
            "textblock": "Based on fundamental study \uff08in Vitro and in Vivo, Pro. Jianjian Li\uff09\uff0c Her2 expression would\n      be changed from negative to positive by cancer irradiation with liner-accelerator at dose\n      6GY or up. The propose of this study is to reveal the irradiation result on Her2 expression\n      in human breast cancer."
        }, 
        "brief_title": "Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast", 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Carcinoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histological confirmed advanced breast cancer\n\n          -  cancer sample can be obtained by fine needle biopsy\n\n          -  IHC and FISH confirmed Her2 negative\n\n          -  radiotherapy indication for local residual cancer\n\n        Exclusion Criteria:\n\n          -  no radiotherapy indication\n\n          -  patient refuse"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "study population is among advanced Chinese breast cancer patient."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01934478", 
            "org_study_id": "QCH20130823-2"
        }, 
        "intervention_browse": {
            "mesh_term": "Mitogens"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast", 
            "Cancer", 
            "Human Epidermal Growth Factor 2 (Her2)", 
            "irradiation"
        ], 
        "lastchanged_date": "August 29, 2013", 
        "location": {
            "contact": {
                "email": "mdji001@gmail.com", 
                "last_name": "youxin ji, M.D.", 
                "phone": "8653268665078"
            }, 
            "facility": {
                "address": {
                    "city": "Qingdao", 
                    "country": "China", 
                    "state": "Shandong", 
                    "zip": "266042"
                }, 
                "name": "Qingdao Central Hospital, Qingdao Cancer Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "ketao lan, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "chunling zhang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "youxin ji, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study on Human Epidermal Growth Factor 2 (Her2) Expression Changes in Human Breast Cancer After Radiotherapy", 
        "overall_contact": {
            "email": "mdji001@gmail.com", 
            "last_name": "youxin ji, M.D.", 
            "phone": "86532-68665078"
        }, 
        "overall_official": {
            "affiliation": "Qingdao Health Bereau", 
            "last_name": "ketao lan, M.D.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "biopsy is obtained by fine needle biopsy\uff0cHer2 is checked by Immunohistochemistry (IHC) and Fluorescence in situ hybridization (FISH).", 
            "measure": "Her2 changes during radiotherapy", 
            "safety_issue": "Yes", 
            "time_frame": "every week up to 6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01934478"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Qingdao Central Hospital", 
            "investigator_full_name": "Youxin Ji", 
            "investigator_title": "Chief, Department of Oncology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Qingdao Central Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Qingdao Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}